|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5266480A
(en)
|
1986-04-18 |
1993-11-30 |
Advanced Tissue Sciences, Inc. |
Three-dimensional skin culture system
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0436597B1
(en)
|
1988-09-02 |
1997-04-02 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
WO1990002909A1
(en)
|
1988-09-06 |
1990-03-22 |
Asarco Incorporated |
Method and burner for melting copper
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5198346A
(en)
|
1989-01-06 |
1993-03-30 |
Protein Engineering Corp. |
Generation and selection of novel DNA-binding proteins and polypeptides
|
|
US5096815A
(en)
|
1989-01-06 |
1992-03-17 |
Protein Engineering Corporation |
Generation and selection of novel dna-binding proteins and polypeptides
|
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
|
WO1991007087A1
(en)
|
1989-11-13 |
1991-05-30 |
Affymax Technologies N.V. |
Spatially-addressable immobilization of anti-ligands on surfaces
|
|
WO1991008756A1
(en)
*
|
1989-12-12 |
1991-06-27 |
Biomedical Research Institute |
Novel malarial sporozoite peptide antigens
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
DK0585287T3
(da)
|
1990-07-10 |
2000-04-17 |
Cambridge Antibody Tech |
Fremgangsmåde til fremstilling af specifikke bindingsparelementer
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
DE69133557D1
(de)
|
1990-08-29 |
2007-03-15 |
Pharming Intellectual Pty Bv |
Homologe rekombination in säugetier-zellen
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
DE69132531T2
(de)
|
1990-12-06 |
2001-09-13 |
Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) |
Verbindungen und ihre Verwendung in einer binären Synthesestrategie
|
|
EP1820858B1
(en)
|
1991-03-01 |
2009-08-12 |
Dyax Corporation |
Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
CA2124087C
(en)
|
1991-11-22 |
2002-10-01 |
James L. Winkler |
Combinatorial strategies for polymer synthesis
|
|
US5233409A
(en)
|
1992-02-25 |
1993-08-03 |
Schwab Karl W |
Color analysis of organic constituents in sedimentary rocks for thermal maturity
|
|
US5359115A
(en)
|
1992-03-26 |
1994-10-25 |
Affymax Technologies, N.V. |
Methods for the synthesis of phosphonate esters
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
KR100310939B1
(ko)
|
1992-10-01 |
2002-06-20 |
추후제출 |
태그로암호화한복합조합화학라이브러리
|
|
US6174530B1
(en)
|
1993-05-05 |
2001-01-16 |
Gryphon Sciences |
Homogeneous polyoxime compositions and their preparation by parallel assembly
|
|
AU691811B2
(en)
|
1993-06-16 |
1998-05-28 |
Celltech Therapeutics Limited |
Antibodies
|
|
US5362899A
(en)
|
1993-09-09 |
1994-11-08 |
Affymax Technologies, N.V. |
Chiral synthesis of alpha-aminophosponic acids
|
|
US6184344B1
(en)
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
US6376653B1
(en)
|
1998-09-28 |
2002-04-23 |
Smithkline Beecham Plc |
Tie2 antagonist antibodies
|
|
WO2001064835A2
(en)
*
|
2000-02-28 |
2001-09-07 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
WO2001088088A2
(en)
*
|
2000-05-18 |
2001-11-22 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
EP1135535A2
(en)
*
|
1998-12-03 |
2001-09-26 |
Phagetech Inc. |
Development of anti-microbial agents based on bacteriophage genomics
|
|
AU2407600A
(en)
*
|
1999-01-15 |
2000-08-01 |
Craig S. Echt |
Microsatellite dna markers and uses thereof
|
|
US6753314B1
(en)
*
|
1999-04-01 |
2004-06-22 |
Curagen Corporation |
Protein-protein complexes and methods of using same
|
|
AU5625500A
(en)
*
|
1999-06-18 |
2001-01-09 |
Emory University |
Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin
|
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
EP1286682B1
(en)
|
2000-06-08 |
2010-03-03 |
Immune Disease Institute, Inc. |
Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury
|
|
EP2896631A1
(en)
*
|
2000-10-10 |
2015-07-22 |
Genentech, Inc. |
Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
|
|
WO2002096948A2
(en)
*
|
2001-01-29 |
2002-12-05 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
|
US20040131607A1
(en)
|
2001-06-08 |
2004-07-08 |
Carroll Michael C. |
Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
|
|
WO2003055982A2
(en)
*
|
2001-12-21 |
2003-07-10 |
Diadexus, Inc. |
Compositions and methods relating to endometrial specific genes and proteins
|
|
WO2003059927A1
(en)
*
|
2001-12-21 |
2003-07-24 |
Diadexus, Inc. |
Compositions and methods relating to endometrial specific genes and proteins
|
|
US7709610B2
(en)
*
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
US7442783B2
(en)
|
2004-03-01 |
2008-10-28 |
The Cbr Institute For Biomedical Research, Inc. |
Natural IgM antibodies and inhibitors thereof
|
|
US20100136684A1
(en)
|
2004-03-01 |
2010-06-03 |
Carroll Michael C |
Natural IgM Antibodies
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
IT1395574B1
(it)
|
2009-09-14 |
2012-10-16 |
Guala Dispensing Spa |
Dispositivo di erogazione
|